Post Q3 EVC Update
EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.
EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.
$WEBC now up over 100% from when the family bought a block of stock at a premium to the prevailing market price, and basically no one I spoke with at the time had any cares. There's another situation right now that has similar dynamics to $WEBC and I'll be talking about it next week. https://t.co/eDlPCsImjn
$NN https://t.co/zzA15wtgMZ
The replies to this suggest that there is still some serious way to go in the AI crash. The $NUAI baggies out in force. https://t.co/sp29sonrpm
Got the $SITC dividend of $3 last night and used it to buy $ARI today which no longer trades as of 4pm today Sometimes you get to buy a luxury apartment tower in Downtown Brooklyn and get two hotels for free Managed to thread the needle Hope to get a hat trick in liquidations with $ELME $SITC and $ARI
Transocean’s 25.6% selloff reflects oil-market shorting and weak Q3 headlines, while debt reduction after the Valaris acquisition could…
CareCloud rebuilt its sales organization under Christopher Langehaug after 18 months without a sales leader, with a second sales rep…
Alpha Metallurgical posted a third consecutive quarterly loss as High Vol A coal margins fell to $14 a ton, while director Kenneth Courtis…
Shift4’s Q3 met guidance, but organic growth is decelerating, management credibility is weakening and leverage reduction remains too slow.
Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…
Vicor earns a Strong Buy after record Q3 results and AI gains, while QXO falls to Hold over capital structure and execution risk.
CareCloud’s Q3 revenue rose 9% through acquisitions but fell 8% pro forma; the RCM consolidator targets 25–30% margins by shifting acquired…
TransMedics reported record Q3 2026 revenue exceeding $200 million, driven by its organ transplant technology business.
JFrog jumped 35% to $100.44 after another beat-and-raise quarter, joining the TL20 Special Situations group.
FULC · long Fulcrum Therapeutics trades below cash as it pursues a likely reverse merger, creating a biotech shell opportunity.
Chiron granted seven executives 195,610 options at a $60 strike, 63% above the market price and above its published valuation range.
Applied Aerospace & Defense reported Q2 revenue growth of 47% to $167 million and $1.13 billion in backlog, supported by missile production…
Oklo’s Q2 progress includes Groves’ first criticality and Aurora agreements, while equity dilution cut its price target to $88 despite a $3…
Kraken Robotics’ C$615 million Covelya acquisition roughly doubles its underwater defense content as mine-warfare risks drive naval…
Build-A-Bear Workshop, the toy retailer.
NIO beat Q2 expectations as delivery growth and higher ES8 and ES9 vehicle margins narrowed losses. Its shares trade at 0.35 times revenue.
Sleep Well Portfolio’s August gains were led by Veeva, CrowdStrike and cybersecurity, while Cellebrite and WiseTech reported early AI…
MiniMed Group's pumps, sensors and dosing algorithm expand recurring CGM and consumables revenue as separation costs roll off and cash flow…
Special-situations survey profiles 31 activist, buyback, M&A and strategic-review cases, including Abercrombie, PagSeguro and Vodafone.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.